Liposome compositions

Details for Australian Patent Application No. 2006284642 (hide)

Owner Novartis AG

Inventors Jiang, Wenlei; Ogorka, Jorg; Kumar, Saran; Zhang, Jia-Ai

Agent Davies Collison Cave

Pub. Number AU-A-2006284642

PCT Pub. Number WO2007/028020

Priority 60/713,273 01.09.05 US

Filing date 31 August 2006

Wipo publication date 8 March 2007

International Classifications

A61K 9/127 (2006.01) Medicinal preparations characterised by special physical form - Liposomes

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/663 (2006.01)

Event Publications

3 April 2008 PCT application entered the National Phase

  PCT publication WO2007/028020 Priority application(s): WO2007/028020

3 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006284650-Osteogenic and anti-adiogenic oxysterols

2006284629-Anchoring system for a catheter